Gianfranco Di Gennaro

Dr. Gianfranco Di Gennaro

Università della Calabria - Dipartimento di Farmacia e Scienze della Salute e della Nutrizione
+2
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2019 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
VCVeronica Cappa
Veronica Cappa
Alessandro MarconAlessandro Marcon
Alessandro Marcon
GGGianfranco Di Gennaro
Gianfranco Di Gennaro
LCLiliya Chamitava
Liliya Chamitava
LCLucia Cazzoletti
Lucia Cazzoletti
MZMaria Elisabetta Zanolin
Maria Elisabetta Zanolin
Health-related quality of life (HRQL) in respiratory diseases has been generally investigated in clinical settings, focusing on a single disorder. In this study on a general population sample, we assessed the relationship between HRQL and several respiratory diseases studied simultaneously (COPD, current (CA) and past (PA) asthma, allergic (AR) and non-allergic (NAR) rhinitis and chronic bronchitis (CB). Controls (n = 328) and cases of NAR (n = 95), AR (n = 163), CB (n = 48), CA (n = 224), PA (n = 126) and COPD (n = 28) were recruited in the centre of Verona in the frame of the Italian multi-case control GEIRD (Gene Environment Interactions in Respiratory Diseases) study; HRQL was measured through the SF-36 questionnaire. The relationships between HRQL (in terms of Physical (PCS) and Mental Component Scores (MCS)), respiratory diseases, and covariates were evaluated. With respect to controls, the adjusted PCS median score was worse in subjects suffering from current asthma (− 1.7; 95%CI:-2.8;-0.6), CB (− 3.8; 95%CI:-5.7;-1.9), and COPD (− 5.6; 95%CI:-8.1;-3.1). MCS was worse in current asthmatics (− 2.2; 95%CI:-4.1;-0.3), CB (− 5.5; 95%CI:-8.7;-2.2), and COPD cases (− 4.6; 95%CI:-8.8;-0.5) as well. To our knowledge, this is the first study in the general population that analyzed HRQL performing a simultaneous comparison of HRLQ in several respiratory disorders. We found that subjects suffering from COPD, CA, and CB had the poorest HRQL. Clinicians should carefully consider the possible impact of respiratory disorders as CB and not only that of CA and COPD.

25 January 2022 in Psychiatry Research Communications
Verified
Journal Article
Open access
Riccardo BortolettoRiccardo Bortoletto
Riccardo Bortoletto
GGGianfranco Di Gennaro
Gianfranco Di Gennaro
GAGiulia Antolini
Giulia Antolini
FMFederica Mondini
Federica Mondini
LPLaura Passarella
Laura Passarella
MCMarco Colizzi
Marco Colizzi
COVID-19 pandemic may affect children's mental health. Children <18 years in-patiently admitted for mental health emergencies between March 2020 and June 2021 were compared to those admitted in the same period of 2018–2019 in terms of sociodemographic and clinical characteristics. There were 49 admissions in the pre-pandemic period and 60 in the pandemic period (IRR: 1.22; 95% CI: 0.84–1.79), with the latter more likely to have a family history of psychiatric disorders, a personal history of physical disturbances, present with suicidal risk, and being diagnosed with an externalizing disorder. This study underscores the increased need for pediatric mental health services.

24 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GMGianmarco Marcianò
Gianmarco Marcianò
ASAntonio Siniscalchi
Antonio Siniscalchi
GGGianfranco Di Gennaro
Gianfranco Di Gennaro
VRVincenzo Rania
Vincenzo Rania
CVCristina Vocca
Cristina Vocca
Luca GallelliLuca Gallelli
Luca Gallelli
Introduction: Neuropathic pain is defined as pain induced by a lesion or disease of the somatosensory nervous system. Pharmacological and non-pharmacological treatments are frequently employed. In the current clinical investigation, we assessed the effects of sex on the safety and effectiveness of medications used to treat neuropathic pain. Methods: We conducted a prospective analysis between 1 February 2021 and 20 April 2024, involving patients with neuropathic pain referred to the Ambulatory of Pain Medicine of “Renato Dulbecco” University Hospital in Catanzaro (Calabria, Italy). Patients over 18 years old with signs of neuropathic pain (Douleur Neuropathique en 4 questionnaire ≥ 4) were included. Exclusion criteria comprised patients with Alzheimer’s disease; patients with nociplastic or nociceptive pain; and patients with neoplasms. Patients with fewer than two accesses to ambulatory care were excluded, as were those who did not sign the informed consent. Clinical data were collected from each enrolled patient and subsequently analyzed, considering clinical outcomes. Sex and gender differences in efficacy were estimated using multivariate linear modeling and propensity-score matching. Results: During the study, 531 patients were screened, and 174 were enrolled (33.5%, mean age 61.5 ± 13.1; 64 males and 110 females, mean age 60.6 ± 13.4 and 61.96 ± 13.0) in accordance with the inclusion and exclusion criteria. Only minor differences in treatment prescription were observed based on age, body mass index, and comorbidities. Smoking, sex, educational level, and body mass index did not induce a significant change in pain perception. Males required slightly higher, though not significantly, doses of drugs for pain control than females. The treatment was not significantly more effective for females than for males. Females did not exhibit a significantly lower number of adverse drug reactions compared to males. Conclusions: The current study found that there are no appreciable differences between the sexes when it comes to the treatment of neuropathic pain.

13 March 2023 in Psychiatry Research Communications
Verified
Journal Article
Open access
DMDario Marin
Dario Marin
GGGianfranco Di Gennaro
Gianfranco Di Gennaro
MBMargherita Baracetti
Margherita Baracetti
RZRossella Zanetti
Rossella Zanetti
MBMatteo Balestrieri
Matteo Balestrieri
Marco ColizziMarco Colizzi
Marco Colizzi
COVID-19 pandemic may have affected youth's mental wellbeing. Youth admissions for mental health emergencies over the 2-year period following the COVID-19 outbreak (March 2020-February 2022) were compared to those occurring in the same period of 2018-2020, with reference to individual and clinical data. The study identified 30 admissions in the pre-pandemic period and 65 (+116.7%) in the post-pandemic period, with the latter being younger, less likely to have a personal psychiatric history, and more likely to receive psychopharmacological treatment. A higher likelihood of earlier, ex novo psychiatric manifestations, requiring medication to reach clinical stability, in the post-COVID era, is suggested.

28 January 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Marco ParilloMarco Parillo
Marco Parillo
FVFederica Vaccarino
Federica Vaccarino
GGGianfranco Di Gennaro
Gianfranco Di Gennaro
SKSumeet Kumar
Sumeet Kumar
JGJohan Van Goethem
Johan Van Goethem
Carlo Augusto MallioCarlo Augusto Mallio
Carlo Augusto Mallio
Brain spaces around (perivascular spaces) and alongside (paravascular or Virchow–Robin spaces) vessels have gained significant attention in recent years due to the advancements of in vivo imaging tools and to their crucial role in maintaining brain health, contributing to the anatomic foundation of the glymphatic system. In fact, it is widely accepted that peri- and para-vascular spaces function as waste clearance pathways for the brain for materials such as ß-amyloid by allowing exchange between cerebrospinal fluid and interstitial fluid. Visible brain spaces on magnetic resonance imaging are often a normal finding, but they have also been associated with a wide range of neurological and systemic conditions, suggesting their potential as early indicators of intracranial pressure and neurofluid imbalance. Nonetheless, several aspects of these spaces are still controversial. This article offers an overview of the current knowledge and magnetic resonance imaging characteristics of peri- and para-vascular spaces, which can help in daily clinical practice image description and interpretation. This paper is organized into different sections, including the microscopic anatomy of peri- and para-vascular spaces, their associations with pathological and physiological events, and their differential diagnosis.

10 September 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
CBCaterina Bernetti
Caterina Bernetti
LCLaura Cea
Laura Cea
ABAndrea Buoso
Andrea Buoso
Federico GrecoFederico Greco
Federico Greco
MRMariagrazia Rossi
Mariagrazia Rossi
Carlo Augusto MallioCarlo Augusto Mallio
Carlo Augusto Mallio
Subacute combined degeneration (SCD) is a neurological disorder primarily caused by vitamin B12 deficiency. This condition leads to progressive demyelination and axonal damage, predominantly affecting the dorsal and lateral columns of the spinal cord. This review provides a comprehensive overview of SCD, detailing its complex etiology, pathophysiology, and clinical presentation. We highlight the critical role of magnetic resonance imaging (MRI) in the diagnostic process, discussing both the characteristic spinal cord findings and the more subtle intracranial abnormalities. Furthermore, we address the diagnostic challenges presented by conditions that mimic SCD in MRI, such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). We conclude by outlining current treatment pathways and identifying key areas for future research, including the use of advanced neuroimaging techniques and the potential for new therapeutic approaches. This updated synthesis aims to provide a clear framework for clinicians and researchers to better understand and manage SCD.